Skip to main content
. Author manuscript; available in PMC: 2020 Feb 15.
Published in final edited form as: Circ Res. 2019 Feb 15;124(4):619–630. doi: 10.1161/CIRCRESAHA.118.312438

Table 2.

Summary of microRNAs regulating pathophysiology of AAAs

miRNA Cell types Potential biomarker Animal model miRNA modulation method Results Target genes References
mir-29 SMC EC FB No Elastase, AngII, Marfan Viral OE
Anti-miR
Inhibition reduces AAA collagens
elastin
62, 65, 95
miR-21 SMC EC
FB
No Elastase, AngII Viral OE
Anti-miR
OE reduces AAA PTEN 50
miR-24 SMC EC
MPh
Yes Elastase, AngII Viral OE
Inhibition
OE reduces AAA CHI3L1 77
miR-33 SMC MPh
HC
No AngII, CCl2 Knockout Inhibition reduces AAA ABCA1 78,80
miR-143
miR-145
SMC FB EC No* AngII Viral OE Knockout OE induces SMC differentiation KLF4 PHACTR4 83
miR-181b MPh EC No AngII Anti-miR Conflicting results TIMP3
elastin
8587
miR-195 SMC Yes AngII AntagomiR Inhibition reduces AAA collagen proteoglycan
elastin
SMAD3
68, 8991
miR-205
miR-712
EC SMC No AngII Anti-miR Inhibition reduces AAA TIMP3 57

SMC: Smooth muscle cells, EC: Endothelial cells, FB: Fibroblasts, MPh: Macrophages, HC: Hepatocytes, AngII: Angiotensin II, OE: Overexpression. *miR-143/145 may be useful biomarkers for vascular disease, but not specific for aneurysms.